Sökning: WFRF:(Xijia Liu) > Pridopidine modifie...
Fältnamn | Indikatorer | Metadata |
---|---|---|
000 | 04097naa a2200481 4500 | |
001 | oai:DiVA.org:umu-192663 | |
003 | SwePub | |
008 | 220221s2022 | |||||||||||000 ||eng| | |
024 | 7 | a https://urn.kb.se/resolve?urn=urn:nbn:se:umu:diva-1926632 URI |
024 | 7 | a https://doi.org/10.1111/ejn.156082 DOI |
040 | a (SwePub)umu | |
041 | a engb eng | |
042 | 9 SwePub | |
072 | 7 | a ref2 swepub-contenttype |
072 | 7 | a art2 swepub-publicationtype |
100 | 1 | a Estévez-Silva, Héctor M.u Umeå universitet,Institutionen för integrativ medicinsk biologi (IMB),Departamento de Ciencias Médicas Básicas, Instituto de Tecnologías Biomédicas (ITB), Universidad de La Laguna, Santa Cruz de Tenerife, Spain4 aut0 (Swepub:umu)eshe0003 |
245 | 1 0 | a Pridopidine modifies disease phenotype in a SOD1 mouse model of amyotrophic lateral sclerosis |
264 | c 2022-02-12 | |
264 | 1 | b John Wiley & Sons,c 2022 |
338 | a electronic2 rdacarrier | |
520 | a Amyotrophic lateral sclerosis (ALS) is a lethal and incurable neurodegenerative disease due to the loss of upper and lower motor neurons, which leads to muscle weakness, atrophy, and paralysis. Sigma-1 receptor (σ-1R) is a ligand-operated protein that exhibits pro-survival and anti-apoptotic properties. In addition, mutations in its codifying gene are linked to development of juvenile ALS pointing to an important role in ALS. Here, we investigated the disease-modifying effects of pridopidine, a σ-1R agonist, using a delayed onset SOD1 G93A mouse model of ALS. Mice were administered a continuous release of pridopidine (3.0 mg/kg/day) for 4 weeks starting before the appearance of any sign of muscle weakness. Mice were monitored weekly and several behavioural tests were used to evaluate muscle strength, motor coordination and gait patterns. Pridopidine-treated SOD1 G93A mice showed genotype-specific effects with the prevention of cachexia. In addition, these effects exhibited significant improvement of motor behaviour 5 weeks after treatment ended. However, the survival of the animals was not extended. In summary, these results show that pridopidine can modify the disease phenotype of ALS-associated cachexia and motor deficits in a SOD1 G93A mouse model. | |
650 | 7 | a MEDICIN OCH HÄLSOVETENSKAPx Medicinska och farmaceutiska grundvetenskaperx Neurovetenskaper0 (SwePub)301052 hsv//swe |
650 | 7 | a MEDICAL AND HEALTH SCIENCESx Basic Medicinex Neurosciences0 (SwePub)301052 hsv//eng |
650 | 7 | a MEDICIN OCH HÄLSOVETENSKAPx Klinisk medicinx Neurologi0 (SwePub)302072 hsv//swe |
650 | 7 | a MEDICAL AND HEALTH SCIENCESx Clinical Medicinex Neurology0 (SwePub)302072 hsv//eng |
653 | a motor function | |
653 | a neuroprotection | |
653 | a preclinical research | |
653 | a pridopidine | |
653 | a sigma-1 receptor | |
653 | a SOD1G93A | |
700 | 1 | a Mediavilla, Tomásu Umeå universitet,Institutionen för integrativ medicinsk biologi (IMB)4 aut0 (Swepub:umu)tome0018 |
700 | 1 | a Giacobbo, Bruno Limau Umeå universitet,Institutionen för integrativ medicinsk biologi (IMB)4 aut0 (Swepub:umu)brli0062 |
700 | 1 | a Liu, Xijiau Umeå universitet,Handelshögskolan vid Umeå universitet4 aut0 (Swepub:umu)xili0017 |
700 | 1 | a Sultan, Fahad R.u Umeå universitet,Institutionen för integrativ medicinsk biologi (IMB)4 aut0 (Swepub:umu)fasu0007 |
700 | 1 | a Marcellino, Danielu Umeå universitet,Institutionen för integrativ medicinsk biologi (IMB)4 aut0 (Swepub:umu)dama0097 |
710 | 2 | a Umeå universitetb Institutionen för integrativ medicinsk biologi (IMB)4 org |
773 | 0 | t European Journal of Neuroscienced : John Wiley & Sonsg 55:5, s. 1356-1372q 55:5<1356-1372x 0953-816Xx 1460-9568 |
856 | 4 | u https://doi.org/10.1111/ejn.15608y Fulltext |
856 | 4 | u https://umu.diva-portal.org/smash/get/diva2:1639371/FULLTEXT02.pdfx primaryx Raw objecty fulltext:print |
856 | 4 | u https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/ejn.15608 |
856 | 4 8 | u https://urn.kb.se/resolve?urn=urn:nbn:se:umu:diva-192663 |
856 | 4 8 | u https://doi.org/10.1111/ejn.15608 |
Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.
Kopiera och spara länken för att återkomma till aktuell vy